Showing results (931-940 of 2,706) with videos related to
Sort By:
Pageof 271
The Lancet. Infectious Diseases|July 5, 2020
Association between mobility patterns and COVID-19 transmission in the USA: a mathematical modelling studyHamada S Badr, Hongru Du, Maximilian Marshall, et al.The Lancet. Infectious Diseases|April 13, 2015
Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trialMasashi Mizokami, Osamu Yokosuka, Tetsuo Takehara, et al.The Lancet. Infectious Diseases|April 24, 2021
Personalised randomised controlled trial designs-a new paradigm to define optimal treatments for carbapenem-resistant infectionsA Sarah Walker, Ian R White, Rebecca M Turner, et al.The Lancet. Infectious Diseases|March 17, 2015
Ledipasvir-sofosbuvir with or without ribavirin to treat patients with HCV genotype 1 infection and cirrhosis non-responsive to previous protease-inhibitor therapy: a randomised, double-blind, phase 2 trial (SIRIUS)Marc Bourlière, Jean-Pierre Bronowicki, Victor de Ledinghen, et al.The Lancet. Infectious Diseases|May 13, 2023
Immunogenicity of novel oral poliovirus vaccine type 2 administered concomitantly with bivalent oral poliovirus vaccine: an open-label, non-inferiority, randomised, controlled trialAmanda L Wilkinson, Khalequ Zaman, Masuma Hoque, et al.The Lancet. Infectious Diseases|August 2, 2002
Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agendaPhilippe J Guerin, Piero Olliaro, Shyam Sundar, et al.The Lancet. Infectious Diseases|September 7, 2002
West Nile virusGrant L Campbell, Anthony A Marfin, Robert S Lanciotti, et al.The Lancet. Infectious Diseases|September 11, 2002
Antifungal drug resistance to azoles and polyenesMar Masiá Canuto, Félix Gutiérrez RoderoThe Lancet. Infectious Diseases|December 7, 2002
Pertussis of adults and infantsC H Wirsing von König, S Halperin, M Riffelmann, et al.Pageof 271